Effect of sorafenib on cisplatin-based chemoradiation in head and neck cancer cells

Despite aggressive chemoradiation (CRT) protocols in the treatment of patients with head and neck squamous cell carcinomas (HNSCC), the outcome is still unfavorable. To improve therapy efficacy we had already successfully tested the multikinase inhibitor sorafenib in combination with irradiation (IR...

Descripción completa

Detalles Bibliográficos
Autores principales: Möckelmann, Nikolaus, Rieckmann, Thorsten, Busch, Chia-Jung, Becker, Benjamin, Gleißner, Lisa, Hoffer, Konstantin, Omniczynski, Maria, Steinmeister, Leonhard, Laban, Simon, Grénman, Reidar, Petersen, Cordula, Rothkamm, Kai, Dikomey, Ekkehard, Knecht, Rainald, Kriegs, Malte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029646/
https://www.ncbi.nlm.nih.gov/pubmed/27015558
http://dx.doi.org/10.18632/oncotarget.8275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029646/
https://www.ncbi.nlm.nih.gov/pubmed/27015558
http://dx.doi.org/10.18632/oncotarget.8275

Ejemplares similares